HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT05400902 · UNKNOWN

Trial details

NCT number: NCT05400902
Sponsor: Binkui Li
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma

Start date: 2023-05-31
Primary completion: 2023-12-31
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.